Observe Medical Asa (OBSRV) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Observe Medical Asa (OBSRV) has a cash flow conversion efficiency ratio of -1.273x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Nkr-30.68 Million ≈ $-3.23 Million USD) by net assets (Nkr24.11 Million ≈ $2.54 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Observe Medical Asa - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how Observe Medical Asa's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Observe Medical Asa debt and liabilities for a breakdown of total debt and financial obligations.
Observe Medical Asa Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Observe Medical Asa ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
QMINES LTD
F:81V
|
N/A |
|
E for L Aim Public Company Limited
BK:EFORL
|
0.037x |
|
Resonance Health Ltd
AU:RHT
|
0.016x |
|
The Navakij Insurance Public Company Limited
BK:NKI
|
0.051x |
|
LEXINGTO GOLD NEW DL-003
F:XX40
|
N/A |
|
KDA Group Inc
V:KDA
|
0.029x |
|
Greenidge Generation Holdings Inc
NASDAQ:GREE
|
-0.002x |
|
Praxis Home Retail Limited
NSE:PRAXIS
|
-0.206x |
Annual Cash Flow Conversion Efficiency for Observe Medical Asa (2016–2024)
The table below shows the annual cash flow conversion efficiency of Observe Medical Asa from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see OBSRV stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Nkr24.11 Million ≈ $2.54 Million |
Nkr-30.68 Million ≈ $-3.23 Million |
-1.273x | -483.24% |
| 2023-12-31 | Nkr112.08 Million ≈ $11.79 Million |
Nkr-24.45 Million ≈ $-2.57 Million |
-0.218x | +41.25% |
| 2022-12-31 | Nkr138.31 Million ≈ $14.55 Million |
Nkr-51.37 Million ≈ $-5.41 Million |
-0.371x | -123.71% |
| 2021-12-31 | Nkr-14.12 Million ≈ $-1.49 Million |
Nkr-22.13 Million ≈ $-2.33 Million |
1.567x | +247.31% |
| 2020-12-31 | Nkr20.35 Million ≈ $2.14 Million |
Nkr-21.64 Million ≈ $-2.28 Million |
-1.064x | -10.69% |
| 2019-12-31 | Nkr14.54 Million ≈ $1.53 Million |
Nkr-13.97 Million ≈ $-1.47 Million |
-0.961x | -93.26% |
| 2018-12-31 | Nkr16.82 Million ≈ $1.77 Million |
Nkr-8.36 Million ≈ $-880.11K |
-0.497x | +42.36% |
| 2017-12-31 | Nkr11.39 Million ≈ $1.20 Million |
Nkr-9.83 Million ≈ $-1.03 Million |
-0.863x | -21.31% |
| 2016-12-31 | Nkr14.70 Million ≈ $1.55 Million |
Nkr-10.45 Million ≈ $-1.10 Million |
-0.711x | -- |
About Observe Medical Asa
Observe Medical ASA develops and commercialize medical technology products for patients, healthcare professionals, and hospitals in Norway, Sweden, the United States, and rest of European countries. It offers Sippi, a digital and automated urine measurement system for urine monitoring and biofilm control; and Biim, a wireless pocketable ultrasound device for display of the ultrasound image and vi… Read more